Skip to content

A Study Comparing an Ayurvedic Eye Application (Rasanjanadi Bidalaka) and Olopatadine Eye Drops in the Treatment of Allergic Conjunctivitis.

A Randomized Controlled Trial to study the efficacy of Rasanjanadi Bidalaka and Olopatadine eye drop in Vataja Abhishyanda with reference to Allergic Conjunctivitis - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106415
Enrollment
62
Registered
2026-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Sane Guruji Arogya Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Individuals experiencing Vataja Abhishyanda, characterized by symptoms such as Toda (Pricking sensation), Sangharsha (Itching sensation), Shishirashruta (Cold lacrimation), and Alpa Shopha (Chemosis). b. Age: 19-60 years c. Irrespective of gender

Exclusion criteria

Exclusion criteria: a. Any significant ocular infections, including corneal ulcers. b. Pregnant and lactating women. Acute keratoconjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis

Design outcomes

Primary

MeasureTime frame
Symptoms like Toda (Pricking sensation), Sangharsha (Foreign body sensation), Achchasruta (Watery discharge), Alpa Shopha (Chemosis), Vishushka Bhava (Feeling of dryness) wil be decreased. Timepoint: Follow up on 3rd, 7th and 8th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shamli Shailendrakumar Pawase

MAMs Sumatibhai Shah Ayurved Mahavidyalaya

zinjad46@gmail.com9028185356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026